Liberia: Prevail Launches Ebola Vaccine Study Expansion

[New Republic] The Partnership for Research on Ebola Virus in Liberia, PREVAIL, Sunday launched the expansion of the Ebola vaccine study at Redemption Hospital. Known as PREVAC under the co-title PREVAIL V, the study will assess three different test vaccine strategies in an effort to find which show the most promise to prevent or quickly control future Ebola outbreaks. It is a continuation of a previous vaccine effort that began in February 2015 in Liberia.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news